FGF23 and chronic kidney disease: In patients with CKD, hyperphosphatemia stimulates the FGF23 synthesis, inhibiting phosphate reabsorption by reducing the expression of the sodium/phosphate co-transporters NaPi-2a and NaPi-2c expression in the proximal tubules.